Factors driving US drug sales growth
Hospitalisation a surrogate for cost and burden of therapy
Ceftriaxone - a better deal than older cephalosporins
Improved health in US elderly due to Medicare?
UK NICE guidance on gemcitabine for pancreatic cancer
US ACIP updates its influenza recommendations
News in brief ...
Rating utilities in RA
Adjunctive amifostine head and shoulders above standard therapy
News in brief ...
High-risk patients benefit from zanamivir for influenza A and B
Migraine patients dissatisfied with treatment in Europe, US
News in brief ...
News in brief ...
Atorvastatin more cost effective than pravastatin, simvastatin
Gynaecological ambulatory-care patterns identify barriers in US
Asthma is costly for MCOs
NSAID algorithm cuts prescribing costs in US health plan
Increase in antidepressant use in Denmark mainly due to SSRIs
Extra cost of abciximab justified in PCI?
Sildenafil uptake lower than expected in Ireland
Pharmacist intervention potentially cost saving in Australia
Multiple NSAID use costs US Medicare managed care
Temozolomide improves QOL in anaplastic astrocytoma
News in brief ...
Japan's new PM promises healthcare reform
Drug prices drop in Norway
News in brief ...
News in brief ...
News in brief ...